Tavilermide
Tavilermide (MIM-D3) is a cyclic peptide and selective Tropomyosin receptor kinase A (TrkA) agonist. It is utilized in research models of dry eye disease, including in vitro assays for neurite outgrowth and in vivo studies for corneal epithelial healing and tear production.
Product Specifications
CAS Number
263251-78-1
Product Name Alternative
MIMD3, MIM-D3, Trk receptor, TrkA, Trkreceptor, Tavilermide
Field of Research
Signal Transduction
Purity
98.98% (May vary between batches)
Solubility
NH4OH:30 mg/mL (51.68 mM) ; H2O:5 mg/mL (8.61 mM)
Smiles
O=C1C=2C (=CC=C (N (=O) =O) C2) OCC[C@@H] (C (NCC (O) =O) =O) NC (=O) [C@H] (CCCCN) NC (=O) [C@H] (CCC (O) =O) N1
Molecular Formula
C24H32N6O11
Molecular Weight
580.54
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2903951-01 20 µg
Recombinant Probable G-protein coupled receptor C56G3.1 (C56G3.1)
Sign In for Pricing
View Details orb2903951-02 100 µg
Recombinant Probable G-protein coupled receptor C56G3.1 (C56G3.1)
Sign In for Pricing
View Details 
